Affinion Group Holdings, Inc. And Affinion Group, Inc. Announce Private Exchange Offers For The 11.625% Senior Notes Due 2015 And 11½% Senior Subordinated Notes Due 2015 And Related Consent Solicitations
| PR Newswire Association LLC |
|
Existing Notes |
CUSIP No. |
Outstanding |
Total Consideration Amount (in Principal |
Exchange Consideration Amount (in |
|
|
008294AB6 |
|
|
|
|
|
00828DAJ0 |
|
|
|
___________
(1) In addition, accrued and unpaid interest to, but not including, the settlement date for the Existing Notes accepted for purchase will be paid on the settlement date in the form of cash.
On
The Exchange Offers are open only to (i) holders who are "qualified institutional buyers," (ii) holders who are institutional "accredited investors" and (iii) holders who are not "U.S. persons," as such terms are defined under the Securities Act of 1933, as amended (the "Securities Act") (such eligible holders are referred to herein as "Eligible Holders").
Concurrently with the Exchange Offers,
The Exchange Offers and Consent Solicitations are scheduled to expire at
Eligible Holders that validly tender, and do not withdraw, their Existing Holdings Notes at or prior to
$1,000 principal amount of new 13.75%/14.50% Senior Secured PIK/Toggle Notes due 2018 ofAffinion Holdings (the "New Holdings Notes");- Series A Warrants (the "Series A Warrants") to purchase 46.1069 shares of
Affinion Holdings' Class B Common Stock, par value$0.01 per share (the "Class B Common Stock"), which in the aggregate represent the right to acquire up to 15% of the pro forma fully diluted ownership ofAffinion Holdings after giving effect to the Exchange Offers but without giving effect to options and restricted stock units ("RSUs") granted underAffinion Holdings' management compensation and incentive plans, which Series A Warrants will be exercisable upon issuance until the tenth anniversary of their issuance, calculated as of the closing date of the Exchange Offers; and - Series B Warrants (the "Series B Warrants") to purchase 239.8612 shares of Class B Common Stock, which together with the Series A Warrants, in the aggregate represent the right to acquire up to 50.1% of the pro forma fully diluted ownership of
Affinion Holdings after giving effect to the Exchange Offers and options and RSUs granted underAffinion Holdings' management compensation and incentive plans, calculated as of the closing date of the Exchange Offers. The Series B Warrants, unlike the Series A Warrants, will not be exercisable until and unless on the fourth anniversary of their issuance, 5% or more aggregate principal amount of New Holdings Notes issued in the Exchange Offers is then outstanding and unpaid, but will otherwise expire and be cancelled without having become exercisable. If the Series B Warrants become exercisable, they will be exercisable until the tenth anniversary of their issuance.
Eligible Holders that validly tender, and do not withdraw, their Existing AGI Notes at or prior to the Consent Time, will be eligible to receive, for each
$1,020 principal amount of new 13.50% Senior Subordinated Notes due 2018 of Affinion Investments (the "New Investments Notes").
We refer to the Series A Warrants and the Series B Warrants, collectively, as the "Warrants," the New Holdings Notes and the New Investments Notes, collectively, as the "New Notes," and the New Notes and the Warrants, collectively, as the "
Eligible Holders that validly tender their Existing Holdings Notes and deliver their consents after the Consent Time but at or prior to the Expiration Time will be eligible to receive, for each
$950 principal amount of New Holdings Notes;- Series A Warrants to purchase 46.1069 shares of Class B Common Stock, which in the aggregate represent the right to acquire up to 15% of the pro forma fully diluted ownership of
Affinion Holdings after giving effect to the Exchange Offers but without giving effect to options and RSUs granted underAffinion Holdings' management compensation and incentive plans, which Series A Warrants will be exercisable upon issuance until the tenth anniversary of their issuance, calculated as of the closing date of the Exchange Offers; and - Series B Warrants to purchase 239.8612 shares of Class B Common Stock, which together with the Series A Warrants, in the aggregate represent the right to acquire up to 50.1% of the pro forma fully diluted ownership of
Affinion Holdings after giving effect to the Exchange Offers and options and RSUs granted underAffinion Holdings' management compensation and incentive plans, calculated as of the closing date of the Exchange Offers. The Series B Warrants, unlike the Series A Warrants, will not be exercisable until and unless on the fourth anniversary of their issuance, 5% or more aggregate principal amount of New Holdings Notes issued in the Exchange Offers is then outstanding and unpaid, but will otherwise expire and be cancelled without having become exercisable. If the Series B Warrants become exercisable, they will be exercisable until the tenth anniversary of their issuance.
Eligible Holders that validly tender their Existing AGI Notes and deliver their consents after the Consent Time but at or prior to the Expiration Time will be eligible to receive, for each
$1,000 principal amount of New Investments Notes.
In addition, holders of Existing Notes validly tendered in the Exchange Offers and not withdrawn will receive on the settlement date for the Exchange Offers accrued and unpaid interest to, but not including, the settlement date in cash.
Consummation of the Exchange Offers and Consent Solicitations is conditioned upon the satisfaction or waiver of the conditions set forth in the confidential offering memorandum and consent solicitation statement (the "Offering Memorandum") and the related letters of transmittal and consent (the "Letters of Transmittal"). Such conditions include, among other things, the valid tender and acceptance by us of at least
Immediately after the consummation of the Exchange Offers, Affinion Investments will exchange with
The New Investments Notes will be guaranteed by
The Exchange Offers and Consent Solicitations are being made solely to Eligible Holders upon the terms and subject to the conditions set forth in the Offering Memorandum and the Letters of Transmittal, each dated
This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any securities. The Exchange Offers and Consent Solicitations are being made and the
About
As a global leader with 40 years of experience,
Forward-Looking Statements
This press release may contain "forward-looking statements." These forward-looking statements include, but are not limited to, the completion of the proposed Exchange Offers, discussions regarding industry outlook,
SOURCE
| Wordcount: | 2714 |



inContact Announces Partnership With Gryphon Networks To Provide Holistic Compliance Solution for Contact Centers
Advisor News
- Midlife planning for women: why it matters and how advisors should adapt
- Tax anxiety is real, although few have a plan to address it
- Trump targets ‘retirement gap’ with new executive order
- Younger investors are engaged and advisors must adapt
- Plugging the hidden budget leaks of retirement
More Advisor NewsAnnuity News
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
- Transamerica introduces RILA with optional income features
- American Life expands into Wyoming and Mississippi markets
More Annuity NewsHealth/Employee Benefits News
- North Dakota small business owners lament rising healthcare costs, credit card swipe fees
- NC's new Medicaid 'compromise' comes at a cruel and frightful cost
- VA to host claims and enrollment clinic in Hutch
- Data from Brown University Provide New Insights into Managed Care (Substantial Variation In Administrative Spending and Profit Across State Insurance Markets, 2023): Managed Care
- Studies from Parth Sheth et al in the Area of Epidemiology Described (Graphical Structure Learning Identifies Hypothesized Mechanisms for Heterogeneous Treatment Effects in Medicaid Population Health Programs): Health and Medicine – Epidemiology
More Health/Employee Benefits NewsLife Insurance News
- Genworth Financial Announces First Quarter 2026 Results
- Transamerica agrees to $57M settlement in cost-of-insurance lawsuit
- The next step for AI in insurance — partnerships to scale
- Your clients are sitting on underused assets
- National Life Group Names Jason Doiron CEO of NLG Capital to Lead the Next Phase of Growth
More Life Insurance News